Phase 3 study for people with Interstitial Lung Disease

Not yet recruiting Phase 3

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Not yet recruiting
Phase Phase 3
Sponsor Bristol-Myers Squibb
Registry number NCT07441408
Started 16 December 2026 Today 16 October 2026 Estimated completion 22 November 2029

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Local Institution - 0287 Camperdown NSW Status not stated
Local Institution - 0290 Chermside QLD Status not stated
Local Institution - 0291 Greenslopes QLD Status not stated
Local Institution - 0293 South Brisbane QLD Status not stated
Local Institution - 0289 Adelaide SA Status not stated
Local Institution - 0288 Frankston VIC Status not stated
Local Institution - 0285 Murdoch WA Status not stated
Local Institution - 0292 Nedlands WA Status not stated
Local Institution - 0286 Melbourne VIC Status not stated
Local Institution - 0284 Wentworthville Australia Status not stated

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age child, adult, older adult
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 2380

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

\- Participants must have participated in either IM027068 or IM0271015 without discontinuing treatment permanently due to withdrawal of informed consent in either IM027068 or IM0271015.

Exclusion Criteria:

* Any disease/condition that, in the investigator's judgment, may pose an unacceptable safety risk for study participation.

* Any AE that resulted in permanent discontinuation of IMP in IM027068 or IM0271015.

* Exhibit symptoms of heart failure at rest.

* History of lung reduction surgery or lung transplant.

* Participants with known PAH (Pulmonary Arterial Hypertension) who has been on single-drug therapy that now requires multi-drug therapy.

* Other protocol-defined Inclusion/Exclusion criteria apply.

Dates on the record

Started 16 December 2026
Estimated completion 22 November 2029
Registry last updated 14 August 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 14 August 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.